2029 related articles for article (PubMed ID: 8482851)
21. Analysis of T-cell and B-cell responses to recombinant M. leprae antigens in leprosy patients and in healthy contacts: significant T-cell responses to antigens in M. leprae nonresponders.
Thole JE; Janson AA; Kifle A; Howe RC; McLean K; Nurilygn A; Filley E; Shannon EJ; Bulla GJ; Hermans J
Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):369-80. PubMed ID: 7594920
[TBL] [Abstract][Full Text] [Related]
22. CD4(+) T cell clones producing both interferon-gamma and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients.
Gerosa F; Nisii C; Righetti S; Micciolo R; Marchesini M; Cazzadori A; Trinchieri G
Clin Immunol; 1999 Sep; 92(3):224-34. PubMed ID: 10479527
[TBL] [Abstract][Full Text] [Related]
23. IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection.
García VE; Uyemura K; Sieling PA; Ochoa MT; Morita CT; Okamura H; Kurimoto M; Rea TH; Modlin RL
J Immunol; 1999 May; 162(10):6114-21. PubMed ID: 10229854
[TBL] [Abstract][Full Text] [Related]
24. IL-2 and IL-12 act in synergy to overcome antigen-specific T cell unresponsiveness in mycobacterial disease.
de Jong R; Janson AA; Faber WR; Naafs B; Ottenhoff TH
J Immunol; 1997 Jul; 159(2):786-93. PubMed ID: 9218596
[TBL] [Abstract][Full Text] [Related]
25. A peptidoglycan protein complex purified from M. leprae cell walls contains most or all immunodominant M. leprae T-cell antigens.
Mutis T; van Schooten WC; de Vries RR
Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):788-93. PubMed ID: 2681461
[TBL] [Abstract][Full Text] [Related]
26. Type 1- and type 2-like lesional skin-derived Mycobacterium leprae-responsive T cell clones are characterized by coexpression of IFN-gamma/TNF-alpha and IL-4/IL-5/IL-13, respectively.
Verhagen CE; van der Pouw Kraan TC; Buffing AA; Chand MA; Faber WR; Aarden LA; Das PK
J Immunol; 1998 Mar; 160(5):2380-7. PubMed ID: 9498780
[TBL] [Abstract][Full Text] [Related]
27. Limiting dilution analysis of the human T cell response to mycobacterial antigens from BCG vaccinated individuals and leprosy patients.
Brett SJ; Kingston AE; Colston MJ
Clin Exp Immunol; 1987 Jun; 68(3):510-20. PubMed ID: 3308217
[TBL] [Abstract][Full Text] [Related]
28. [Immunosuppression in leprosy].
Sasiain MC; de la Barrera S
Medicina (B Aires); 1989; 49(3):213-5. PubMed ID: 2535042
[TBL] [Abstract][Full Text] [Related]
29. T cell defect in lepromatous leprosy is reversible in vitro in the absence of exogenous growth factors.
Mohagheghpour N; Gelber RR; Engleman EG
J Immunol; 1987 Jan; 138(2):570-4. PubMed ID: 2947952
[TBL] [Abstract][Full Text] [Related]
30. IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones.
Parronchi P; De Carli M; Manetti R; Simonelli C; Sampognaro S; Piccinni MP; Macchia D; Maggi E; Del Prete G; Romagnani S
J Immunol; 1992 Nov; 149(9):2977-83. PubMed ID: 1401925
[TBL] [Abstract][Full Text] [Related]
31. Leprosy patients with lepromatous disease have an up-regulated IL-8 response that is unlinked to TNF-alpha responses.
Hasan Z; Mahmood A; Zafar S; Khan AA; Hussain R
Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):35-44. PubMed ID: 15217317
[TBL] [Abstract][Full Text] [Related]
32. Evidence for the presence of M. leprae reactive T lymphocytes in patients with lepromatous leprosy.
Nath I; Sathish M; Jayaraman T; Bhutani LK; Sharma AK
Clin Exp Immunol; 1984 Dec; 58(3):522-30. PubMed ID: 6391762
[TBL] [Abstract][Full Text] [Related]
33. Selective expansion of cytotoxic T lymphocytes with a CD4+CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with Hepatitis B virus.
Barnaba V; Franco A; Paroli M; Benvenuto R; De Petrillo G; Burgio VL; Santilio I; Balsano C; Bonavita MS; Cappelli G
J Immunol; 1994 Mar; 152(6):3074-87. PubMed ID: 7511637
[TBL] [Abstract][Full Text] [Related]
34. Differential interferon- gamma production characterizes the cytokine responses to Leishmania and Mycobacterium leprae antigens in concomitant mucocutaneous leishmaniasis and lepromatous leprosy.
Matos DS; Azeredo-Coutinho RB; Schubach A; Conceição-Silva F; Baptista C; Moreira JS; Mendonça SC
Clin Infect Dis; 2005 Jan; 40(2):e5-12. PubMed ID: 15655736
[TBL] [Abstract][Full Text] [Related]
35. Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro.
Kaplan G; Gandhi RR; Weinstein DE; Levis WR; Patarroyo ME; Brennan PJ; Cohn ZA
J Immunol; 1987 May; 138(9):3028-34. PubMed ID: 3106496
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and specificity of the enhancing effect of three types of interleukin 2 on T cell responsiveness in 97 lepromatous leprosy patients of mixed ethnic origin.
Barnass S; Mace J; Steele J; Torres P; Gervasoni B; Ravioli R; Terencio J; Rook GA; Waters MF
Clin Exp Immunol; 1986 Apr; 64(1):41-9. PubMed ID: 2426020
[TBL] [Abstract][Full Text] [Related]
37. Mycobacterium leprae-specific protein antigens defined by cloned human helper T cells.
Ottenhoff TH; Klatser PR; Ivanyi J; Elferink DG; de Wit MY; de Vries RR
Nature; 1986 Jan 2-8; 319(6048):66-8. PubMed ID: 2417123
[TBL] [Abstract][Full Text] [Related]
38. Alterations in T cell signal transduction by M. leprae antigens is associated with downregulation of second messengers PKC, calcium, calcineurin, MAPK and various transcription factors in leprosy patients.
Chattree V; Khanna N; Rao DN
Mol Immunol; 2007 Mar; 44(8):2066-77. PubMed ID: 17046060
[TBL] [Abstract][Full Text] [Related]
39. Cytokines in mycobacterial infections: in vitro and ex vivo studies.
Flad HD; Gercken J; Hübner L; Schlüter C; Pryjma J; Ernst M
Arch Immunol Ther Exp (Warsz); 1995; 43(2):153-8. PubMed ID: 8744732
[TBL] [Abstract][Full Text] [Related]
40. Human atopen-specific types 1 and 2 T helper cell clones.
Wierenga EA; Snoek M; Jansen HM; Bos JD; van Lier RA; Kapsenberg ML
J Immunol; 1991 Nov; 147(9):2942-9. PubMed ID: 1680923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
